Notably, the interaction of epidermal growth factor receptors (EGFR) with signal transducer and activator of transcription 3 (STAT3) or the constitutive activation of EGFR variant III/STAT3 pathway enhances the COX2 signaling and favors glioma angiogenesis. This evidence concerns the gene EGFR and central nervous system cancer.